Replies to post #23087 on BioCurex, Inc.(fka BOCX)

[HALF FULL GLASS]

MCD stated,"IMO, Recaf could help take away the false positives of these tests."

I believe we both see this as a positive item.

Mcd stated,"But in doing that, a positive Recaf alone would raise more issues about what type of cancer is actually present."

Who said that this new test is going to raise a question if Recaf shows a positive reading. Remember this article is stating that Recaf combined will take away any false positives.

Why can't we stop right there. Why would the doctor have to say any more (In this scenario).
The test would just be marketed the same as it was but would eliminate the false positives that we see so often in todays current test.

Using Recaf to take away the false positives of PSA has been discussed for years. So far, no tests sold.

This is the same scenario Gold has been preaching about. Supposedly Abbott picked up another conpany for PSA testing and yet they have not produced a marketable product. Will it be in the next year or 2 or 3? We do not know.

These things take time. What we do see is what Quan stated earlier,"But I do know that the barrier to entry into clinical practice is extremely high for any new device / product. I think a lot of people under-estimate how costly and difficult this is, and why it is largely the domain of huge multinational companies.

if the product holds up to clinical scrutiny, I think the dam will bust at some point and it will take off."